期刊文献+

耐顺铂人鼻咽癌细胞系HNE1/CDDP的建立及其生物学特性的研究 被引量:1

Establishment of a cisplatin-induced human nasopharyngeal carcinoma drug-resistant cell line and its biological characteristics
原文传递
导出
摘要 目的:建立耐顺铂(CDDP)的鼻咽癌耐药细胞系HNE1/CDDP,并研究其生物学特性。方法:采用逐步递增培养基中CDDP的方法,体外连续培养建成一株耐CDDP的人鼻咽癌耐药细胞系HNE1/CDDP。用MTT法测定该耐药细胞系对多种抗癌药的敏感性,观察亲本细胞系和耐药细胞系的形态学差异,用生长曲线分别计算亲本细胞系和耐药细胞系的倍增时间,以流式细胞技术检测亲本细胞系和耐药细胞系的周期分布,观测亲本和耐药细胞系黏附、运动和侵袭能力的差别。结果:历时10个月建成人鼻咽癌CDDP耐药细胞系HNE1/CD-DP,能在含CDDP 1mg/L的培养基中稳定生长并传代,其对CDDP的耐药指数为5.83,并与卡铂、奥沙利铂、足叶乙甙等多种抗癌药存在不同程度的交叉耐药性;体外群体倍增时间较亲代细胞延长;细胞周期分析发现其S期与G2/M期细胞减少、G0/G1期细胞增多;HNE1和HNE1/CDDP细胞株的黏附、运动、侵袭能力无明显差别。结论:HNE1/CDDP细胞具有耐药表型,且耐药性稳定,能作为体外研究耐药的模型。 Objective:To establish a CDDP-resistant cell line from human nasopharyngeal carcinoma and evaluate its biological characteristics. Method: By continuously exposing and gradually increasing dose of cisplatin (CDDP), a resistant nasopharyngeal carcinoma cell line (HNE1/CDDP) was established. Drug sensitivity of this celt line was detected by MTT assay; the alterations of its biological characteristics were determined using light mi- croscopy, cell counting and flow cytometry (FCM) ; its ability of adhesion, migration and invasion were also eval- uated. Result: HNE1/CDDP cell line was developed after 10 months with stable resistance to cisplatin with the resistance index was 5.83. HNE1/CDDP cell exhibited cross resistance to many other chemotherapeutic agents (carboplatin, oxaliplatin and etoposide, etc). The morphology of HNE1/CDDP changed; doubling time prolonged; and the cell number of S-phase and G2/M-phase decreased while of G0/G1 phase increased compared with parental cells. The ability of adhesion, migration and invasion had no difference between the parental and the resistant cells. Conclusion: HNE1/CDDP cell line shows the typical and stable resistant phenotype and can be used as a research model.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2008年第21期992-994,997,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 广东省医学科研基金(No:B2005099)
关键词 鼻咽肿瘤 CDDP 耐药性 细胞系 Nasopharyngeal carcinoma Cisplatin Drug resistance Cell line
  • 相关文献

参考文献7

二级参考文献9

共引文献98

同被引文献8

  • 1WHO.A practical guide for designing and conducting influenza diseaseburden studies:section 2:Studies indirectly measuring the disease bur-den of influenza[R].2009.13-17.
  • 2Zheng G, Peng F, Ding R, et al. Identification of proteins responsible for the multiple drug resistance in 5 - fluorouracil - induced breast can- cer cell using proteomics analysis[J ]. J Cancer Res Clin Oncol, 2010, 136(10) :1477 - 1488.
  • 3Hart B,Xie H,Chen Q, et al. Sensitizing hormone refractory prostate cancer cells to drug treatment by targeting 14 3 3sigma [J].Mol Cancer Ther, 2006,5 (4) : 903 - 912.
  • 4Liu S, Howell P, Ren S,et al. The 14 - 3 - 3sigma gene promoter is methylated in both human melanocytes and melanoma[J]. BMC Can- cer, 2009,9 : 162 - 168.
  • 5Chan SY, To KF, Leung SF, et al. 14 - 3 - 3sigma expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma [ J ]. Oncol Rep,2010,24(4) :949 - 955.
  • 6Yi B, Tan SX, Tang CE, et al. Inactivation of 14 - 3 - 3 sigma by promoter methylation correlates with metastasis in nasopharyngeal car- cinoma[J]. J Cell Biochem,2009,106(5) :858 866.
  • 7Liang S, Xu Y, Shen G, et al. Gene expression and methylation status of 14 - 3 - 3sigma in human renal carcinoma tissues[J]. IUBMB Life, 2008,60 (8) :534 - 540.
  • 8胡晓晔,邹青峰,金川,李卫东,陈文晟,马磊.紫杉醇联合吉西他滨治疗晚期耐药鼻咽癌的临床观察[J].国际医药卫生导报,2010,16(4):459-462. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部